{"id":"W1998943227","doi":"10.1056/nejmoa0907845","title":"A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":2076,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. John’s Health Sciences Centre","funders":"Genentech; Servier; Cytokinetics; Covis Pharma; Celladon Corporation; McGill University; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; Biogen; GlaxoSmithKline; Louisiana Board of Regents; Bristol-Myers Squibb; AstraZeneca; Robert Wood Johnson Foundation; Amgen; Pfizer","keywords":"Medicine; Darbepoetin alfa; Kidney disease; Type 2 diabetes; Anemia; Diabetes mellitus; Internal medicine; Disease; Clinical trial; Hemoglobin; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01367268627852847,"score_gpt":0.284810498852715,"score_spread":0.2711378125741866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}